Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective Trial for the Diagnosis and Treatment of Intracranial Germ Cell Tumours
2009-018072-33Phase 4Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Jun 2011
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cisplatin, etoposide, ifosfamide and carboplatin in intracranial germ cell tumor (ICGCT), Nongerminomatous germ cell tumor of the central nervous system and germinoma, sponsored by Universitätsklinikum Münster. Primary endpoint: Event-free survival. Started Jun 2011; status: completed.
02
Drugs
cisplatinetoposideifosfamidecarboplatin
03
Conditions
intracranial germ cell tumor (ICGCT)Nongerminomatous germ cell tumor of the central nervous systemgerminoma
Beyond the preview
Go deeper on 2009-018072-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018072-33.